# Qwen direction review

On 2026-09-15 the user explicitly prioritized Qwen and authorized local next steps. The existing [ChatGPT project conversation](https://chatgpt.com/c/6aa696d6-be98-83ec-aedc-149ad9680582) reviewed the proposed scope. This is advisory LLM review, not independent execution or qualified clinical adjudication.

The review supported reusing the exact, never-run v2 Qwen candidate instead of inventing a third prompt. It requested a common future parser for both arms, separate historical versus prospective-parser results, a machine-readable instruction diff, the pinned non-thinking Qwen recipe, no MedGemma framing logic or constrained decoding, and a balanced 20-generation design with no repairs/retries/favorable-repeat selection.

Those requirements are incorporated. The local parser sensitivity analysis additionally found that two recovered whitespace quotations are offset by two newly rejected ambiguous exact spans: 56 retain validity, two gain diagnostic validity, two lose it. Official historical outputs remain unchanged. The new ambiguity flags overlap the inherited review queue; all 12 inherited items remain unresolved.

The review suggested a looser engineering threshold of at least 58/60. This proposal instead preserves the existing strict 60/60 valid-and-identical advancement gate, so it does not relax acceptance after seeing failures. Technical validity must be followed by blinded qualified review of report entailment, then secondary organizer comparison. More abstention alone is not improvement.

The review of the completed public code will be recorded after publication. No new Qwen generation or clinical benefit is claimed.
